GT201400071A - Combinación terapéutica para el tratamiento de cáncer - Google Patents

Combinación terapéutica para el tratamiento de cáncer

Info

Publication number
GT201400071A
GT201400071A GT201400071A GT201400071A GT201400071A GT 201400071 A GT201400071 A GT 201400071A GT 201400071 A GT201400071 A GT 201400071A GT 201400071 A GT201400071 A GT 201400071A GT 201400071 A GT201400071 A GT 201400071A
Authority
GT
Guatemala
Prior art keywords
cancer treatment
therapeutic combination
combinations
treatment
therapeutic
Prior art date
Application number
GT201400071A
Other languages
English (en)
Inventor
Dennis R Knocke
Joseph B Nester
Ioannis Papasotiriou
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT201400071A publication Critical patent/GT201400071A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LA PRESENTE INVENCIÓN SE RELACIONA CON COMBINACIONES TERAPÉUTICAS QUE COMPRENDEN UN AGENTE ANTINEOPLÁSICO BASADO EN PLATINO Y UN EXTRACTO DE UNA ESPECIE DEL GÉNERO NERIUM, ASÍ COMO MÉTODOS PARA USAR DICHAS COMBINACIONES EN EL TRATAMIENTO DE PACIENTES QUE SUFREN DE DETERMINADOS TIPOS DE CÁNCER
GT201400071A 2011-10-20 2014-04-15 Combinación terapéutica para el tratamiento de cáncer GT201400071A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161549386P 2011-10-20 2011-10-20

Publications (1)

Publication Number Publication Date
GT201400071A true GT201400071A (es) 2015-09-17

Family

ID=48141445

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201400071A GT201400071A (es) 2011-10-20 2014-04-15 Combinación terapéutica para el tratamiento de cáncer

Country Status (13)

Country Link
US (2) US20130209579A1 (es)
EP (2) EP3711754A1 (es)
JP (1) JP6255346B2 (es)
CN (2) CN110269940A (es)
AU (3) AU2012325819B2 (es)
BR (1) BR112014009421A2 (es)
CA (1) CA2852274C (es)
GT (1) GT201400071A (es)
IL (2) IL231987B (es)
IN (1) IN2014KN00796A (es)
MX (2) MX365635B (es)
RU (2) RU2014120179A (es)
WO (1) WO2013059753A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2346518B1 (en) * 2008-10-14 2020-09-02 Nerium Biotechnology, Inc. Process for extracting cardiac glycosides from nerium oleander and compositions
US20180085377A1 (en) * 2015-04-22 2018-03-29 Syn-Nat Products Enterprise LLC Co-crystal composition and its pharmaceutical use
CN108135920A (zh) * 2015-10-05 2018-06-08 努卡那有限公司 组合疗法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1299100C (en) 1986-05-13 1992-04-21 Huseyin Ziya Ozel Extracts of nerium species, methods of preparation and use therefor
JP2002526452A (ja) 1998-09-24 2002-08-20 オゼル・ファーマスーティカルズ・インコーポレイテッド キョウチクトウ抽出物、その医薬組成物及びその調整方法
US7407675B2 (en) * 2002-12-27 2008-08-05 The Trustees Of Columbia University In The City Of New York Anti-neoplastic compositions comprising extracts of black cohosh
US20060205679A1 (en) * 2004-10-22 2006-09-14 Azaya Therapeutics, Inc. Topical and oral formulations of cardiac glycosides for treating skin diseases
US7402325B2 (en) 2005-07-28 2008-07-22 Phoenix Biotechnology, Inc. Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander
EP1803461A1 (en) * 2005-12-27 2007-07-04 Heinz-Herbert Fiebig Therapeutic use of an extract from the leaves of Nerium oleander
PL2173337T3 (pl) 2007-08-06 2014-11-28 Univ Ohio Fosfaplatyny i ich zastosowanie w leczeniu raków opornych na cisplatynę i karboplatynę
EP2346518B1 (en) * 2008-10-14 2020-09-02 Nerium Biotechnology, Inc. Process for extracting cardiac glycosides from nerium oleander and compositions

Also Published As

Publication number Publication date
MX2014004527A (es) 2014-09-15
EP2768498A1 (en) 2014-08-27
JP2014530878A (ja) 2014-11-20
EP3711754A1 (en) 2020-09-23
AU2012325819B2 (en) 2017-08-03
BR112014009421A2 (pt) 2017-04-18
RU2014120179A (ru) 2015-11-27
RU2017136415A3 (es) 2021-02-08
IL231987B (en) 2020-07-30
MX365635B (es) 2019-06-10
IL275636A (en) 2020-08-31
IN2014KN00796A (es) 2015-10-02
CA2852274C (en) 2019-08-06
EP2768498B1 (en) 2020-03-04
RU2017136415A (ru) 2019-02-08
JP6255346B2 (ja) 2017-12-27
NZ623550A (en) 2016-06-24
AU2012325819A1 (en) 2014-04-24
MX2019006685A (es) 2019-08-21
WO2013059753A1 (en) 2013-04-25
AU2019203577A1 (en) 2019-06-13
AU2017254875A1 (en) 2017-11-23
CA2852274A1 (en) 2013-04-25
CN110269940A (zh) 2019-09-24
US20130209579A1 (en) 2013-08-15
EP2768498A4 (en) 2015-06-17
US20190343908A1 (en) 2019-11-14
CN104093405A (zh) 2014-10-08
IL231987A0 (en) 2014-05-28

Similar Documents

Publication Publication Date Title
SV2017005489A (es) Terapias de combinación para el tratamiento de cánceres
UY36307A (es) Terapias combinadas para el tratamiento del cáncer
ECSP24031979A (es) Compuestos terapéuticamente activos y sus métodos de uso
CL2018001152A1 (es) Composiciones y métodos para el tratamiento del cáncer
CR20150376A (es) Compuestos sustituidos de pirrolopirimidina, compuestos de los mismos y metodos de tratamiento con los mismos
CL2018003123A1 (es) Terapia de combinación para el tratamiento del cáncer
PH12016501139A1 (en) Bicyclic heterocycle compounds and their uses in therapy
CL2015002807A1 (es) Terapia de combinación
NI201400095A (es) Metodos para el tratamiento del cáncer de pulmon de celulas no pequeñas utilizando terapia combinada de inhibidor tor cinasa.
IL242386B (en) Use of Aribolin and Lavetinib as a combination therapy for cancer treatment
NI201400112A (es) Tratamiento del cáncer con inhibidores tor cinasa
NI201400111A (es) Tratamiento del cáncer con inhibidores tor cinasa
MX2015014046A (es) Combinaciones de farmacos para tratar cancer.
MX2015014599A (es) Terapia de combinacion que comprende un inhibidor de tor cinasa y un analogo de citidina para tracar cancer.
ECSP15011764A (es) Antiandrógenos para el tratamiento del cáncer de próstata resistente a la castración no metastásico
MX2020001727A (es) Terapia de combinacion.
NI201500063A (es) Tratamiento de cáncer con pomalidomida en un individuo con daño renal
CR20140400A (es) Terapia combinada para el tratamiento del cancer de ovario
DOP2018000011A (es) Sales y profármacos de 1-metil-d-triptófano
GT201400071A (es) Combinación terapéutica para el tratamiento de cáncer
UY35033A (es) Formulación en comprimidos de un inhibidor de la fosfatidilinositol 3-cinasa
CR20140480A (es) Metodos para tratar el cancer usando inhibidor de pi3k e inhibidor de mek
CR20150134A (es) Arry-520 para uso en el tratamiento del cáncer en un paciente con aag baja
MX2017013668A (es) Terapia de combinacion de agente anti-fuctactico y agente anti-cancer y composiciones para el tratamiento de cancer.
DOP2017000174A (es) Terapias de combinación para el tratamiento de cánceres